Inflammatix has appointed Amy Boyle as its chief operating officer. Boyle has 30 years of commercial medical device experience, with expertise in strategy, market development, sales and marketing, commercial operations, and manufacturing.
Most recently, she served as vice president, strategy, planning, and marketing for the health solutions division of Flex. Prior to that, she was vice president, marketing for the urology division of Coloplast, where she led global expansion and growth of the surgical urology business, and launched the firm's endourology portfolio in the US.
Previously, Boyle was executive vice president of marketing for Imris and spent five years at St. Jude Medical, first as vice president, marketing, international, responsible for cardiovascular businesses, and then as vice president, corporate brand and marketing. She also spent 17 years with Medtronic in Canada and the US in a variety of sales roles, including regional vice president of sales for the cardiac rhythm management business.